Researchers from the Universities of Dundee, Glasgow and Strathclyde have been awarded pound 691,000 as part of the first wave of funding made available through Prostate Cancer UK’s ambitious new research strategy. A colossal pound ...
Tags: Universities of Dundee, Researchers, Prostate Cancer UK
Acceleron Pharma has announced that the Gynecologic Oncology Group (GOG) has sponsored its phase 2 study of dalantercept. Patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer are taking part in the ...
US-based Smiths Medical has gained US marketing rights for its CADD-Solis variable infusion profile (VIP) ambulatory infusion system, following the US Food and Drug Administration (FDA) approval. The multi-therapy infusion system, which ...
Tags: FDA, therapy infusion system, Medical
The US Food and Drug Administration (FDA) has approved Sun Pharmaceutical Industries' abbreviated new drug application (ANDA) for Doxorubicin HCl Liposome Injection USP, 2 mg/ml. Doxorubicin HCl Liposome Injection USP, 2 mg/ml, which is ...
Tags: FDA, Sun Pharma, Pharmaceutical
MolecularMD has obtained an exclusive license to LKB1 for diagnostic, prognostic and predictive uses in non-small cell lung cancer patients. The Dana-Farber Cancer Institute, the Massachusetts General Hospital, the University of North ...
UK-based supermarket chain Sainsbury's is recalling its own-brand Lemon Thyme as it may be contaminated with Salmonella, according to the UK Food Standards Agency (FSA). The product subject to recall is Sainsbury's Lemon Thyme, 15g, ...
Tags: Sainsbury's, supermarket, UK, Lemon Thyme, Salmonella, FSA
The USFDA has accepted for filing Astellas Pharma's supplemental new drug application (sNDA) for Tarceva (erlotinib) tablets for a genetically distinct form of advanced lung cancer. Astellas is seeking approval to use Tarceva as the ...
Aileron Therapeutics has secured the second tranche in its series D financing, meaning the overall total has now reached $42 million (pound 26 million). This payment followed the successful progression of the company's ALRN-5281 lead ...
The European Commission (EC) has approved broader indication of Janssen-Cilag International's oral, once-daily medication Zytiga (abiraterone acetate). Licence extension includes the use of Zytiga as a combination therapy along with ...
Tags: Zytiga, Janssen Europe, medical
The US Food and Drug Administration (FDA) has granted 510(k) clearance to AngioDynamics' BioFlo peripherally inserted central catheters (PICCs) with a permanent and non-eluting integral polymer Endexo technology. The BioFlo PICCs is ...
Tags: FDA, clearance, PICCs, BioFlo PICCs, PASV Valve technology
Ledford Medical Electronics has entered into an agreement to expand the sales of Naviscan's organ-specific PET Scanner for use in breast applications in the US. The company said the breast application of the scanner is known as Positron ...
Tags: Ledford Medical, agreement, expand sales, PET Scanner, breast application
University of California San Francisco (UCSF) Medical Center has purchased BSD Medical's BSD-2000 hyperthermia system. UCSF Medical Center is involved in providing advanced technology and care to patients suffering with cancer. By ...
Tags: UCSF, BSD Medical, BSD-2000 hyperthermia system, cancer
Janssen's Zytiga indicated for metastatic castration-resistant prostate cancer(mCRPC),has won FDA approval for use in patients who have not received chemotherapy. The oral,once-daily medication was previously used in combination with ...
Roche Group member, Genentech has received US Food and Drug Administration (FDA) official approval of priority review designation for trastuzumab emtansine Biologics License Application (BLA). Trastuzumab Emtansine is designed to treat ...
GlaxoSmithKline (GSK) has received FDA approval for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The approval is based on the results of the randomized, ...
Tags: advanced soft tissue sarcoma, STS, soft tissue sarcomas, GlaxoSmithKline